Spruce Financial Statements From 2010 to 2025
| SPRBDelisted Stock | USD 0.07 0.0004 0.56% |
Check Spruce Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Spruce Biosciences' main balance sheet or income statement drivers, such as , as well as many indicators such as . Spruce financial statements analysis is a perfect complement when working with Spruce Biosciences Valuation or Volatility modules.
Spruce |
Spruce Biosciences Company Return On Equity Analysis
Spruce Biosciences' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Spruce Biosciences Return On Equity | -1.01 |
Most of Spruce Biosciences' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Spruce Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, Spruce Biosciences has a Return On Equity of -1.007. This is 95.8% lower than that of the Biotechnology sector and 97.24% lower than that of the Health Care industry. The return on equity for all United States stocks is notably higher than that of the company.
Spruce Biosciences Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Spruce Biosciences's current stock value. Our valuation model uses many indicators to compare Spruce Biosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Spruce Biosciences competition to find correlations between indicators driving Spruce Biosciences's intrinsic value. More Info.Spruce Biosciences is rated fifth in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Spruce Biosciences by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Spruce Biosciences' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Spruce Biosciences Financial Statements
Spruce Biosciences stakeholders use historical fundamental indicators, such as Spruce Biosciences' revenue or net income, to determine how well the company is positioned to perform in the future. Although Spruce Biosciences investors may analyze each financial statement separately, they are all interrelated. For example, changes in Spruce Biosciences' assets and liabilities are reflected in the revenues and expenses on Spruce Biosciences' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Spruce Biosciences. Please read more on our technical analysis and fundamental analysis pages.
Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. Spruce Biosciences, Inc. was incorporated in 2014 and is headquartered in Daly City, California. Spruce Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 17 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Consideration for investing in Spruce Pink Sheet
If you are still planning to invest in Spruce Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Spruce Biosciences' history and understand the potential risks before investing.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |